Edition:
United Kingdom

Juno Therapeutics Inc (JUNO.OQ)

JUNO.OQ on NASDAQ Stock Exchange Global Select Market

86.56USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$86.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
911,031
52-wk High
$86.75
52-wk Low
$19.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 21.27 -0.964
Mar '17 19.33 -0.792
FY 2016 Dec '16 21.15 -0.512
Sep '16 20.83 -0.557
Jun '16 27.60 -0.639
Mar '16 9.77 -0.716
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 9 14.61 24.30 0.00 11.25
Quarter Ending Jun-18 9 14.73 25.30 0.00 11.25
Year Ending Dec-18 11 70.60 135.50 0.00 54.15
Earnings (per share)
Quarter Ending Mar-18 8 -0.96 -0.67 -1.34 -0.92
Quarter Ending Jun-18 8 -0.95 -0.67 -1.21 -0.68
Year Ending Dec-18 10 -3.86 -2.68 -4.87 -3.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 58.97 110.72 5.77
Price to Book (MRQ) 4.88 13.56 5.41
Price to Tangible Book (MRQ) 7.64 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 73.98 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -22.95 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago 91.45 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -50.88 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -12.85 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 5.08 5.30 2.97
LT Debt to Equity (MRQ) 3.43 22.82 12.22
Total Debt to Equity (MRQ) 3.43 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -345.77 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -365.66 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -359.90 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -354.36 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 154,923 22,602,130 855,673,508
Net Income/Employee (TTM) -548,991 2,968,748 100,656,226
Receivable Turnover (TTM) 8.40 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.06 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -21.22 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -23.70 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -27.92 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 335.66 -- --
EPS (TTM) % 10.89 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Juno Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.21 0.61 99 53
13 Week 49.81 42.52 99 62
26 Week 83.24 69.31 99 77
52 Week 50.69 27.72 99 50
YTD 131.35 103.17 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.29%
# of Holders: 335
Total Shares Held: 92,806,572
3 Mo. Net Change: -993,402
# New Positions: 59
# Closed Positions: 25
# Increased Positions: 179
# Reduced Positions: 102
# Net Buyers: 77
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.